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Sunmaary 
We established  a novel monoclonal antibody, RP/14, that can protect B cells from apoptosis 
induced by irradiation or dexamethasone. A molecule recognized by RP/14 (the RP antigen) 
was expressed on B cells with B220b~  t, IgM  d~, and IgD  br~ht. Immunoprecipitation  experiments 
revealed that RP/14 recognized a monomeric protein with an approximate molecular mass of 
105 kD. Stimulation orB cells with RP/14 for 48 h induced B cell proliferation and blastogenesis. 
In contrast to B cells of wild-type mice, X-linked immunodeficient  (XID) B cells did not proliferate 
upon stimulation with RP/14, although the RP antigen was expressed to the same extent as 
that of wild-type B cells. These results suggest that the RP antigen-mediated signaling pathway 
is important for rescuing B cells from apoptosis and is deficient in XID B cells. 
B  cells have to get through several selection steps during 
differentiation from an immature to a mature stage B 
cell, or into an antibody-secreting cell (reviewed in 1 and 2). 
Only B cells that have experienced selections are allowed to 
join a mature B cell pool and to differentiate into antibody- 
secreting cells with appropriate stimuli. These sdections would 
enable mice to maintain a stable B cell pool without autoreac- 
rive B cells particularly against cell membrane-anchored stir- 
antigens (2-4) and to produce effdently antibodies with ade- 
quate specificity and affinity (1, 5, 6). An execution of these 
selections would involve apoptosis, survival, or proliferation 
of B cells. Analysis of double transgenic mice, reported by 
Goodnow et al. (3 and reviewed in 4), revealed that apop- 
tosis is critically  involved in a negative selection that trims 
off B cells bearing aberrant specificity against self-antigens. 
Autoantigen itsdf or in concert with other signals would 
trigger apoptosis in these hazardous cells. A positive sdec- 
tion requires a condition where only cells that receive a signal 
are able to survive or grow. Otherwise, cells undergo apop- 
tosis. In the germinal center, only cells bearing a surface im- 
munoglobulin with suffcient affinity against an antigen are 
allowed to survive and grow (5). In this situation, stimula- 
tory signals such as antigen itsdf or the CD40 ligand are 
shown to protect cells from apoptosis and induce survival 
or proliferation (5, 6). In either selection,  apoptosis seems 
to play an essential role, and a decision whether cells undergo 
apoptosis or are allowed to survive or grow would be the 
most critical part of the selections. Accordingly a signal that 
is capable of inducing or blocking apoptosis can be impli- 
cated  in  the  pivotal  systems  for  selecting  B  cells. An 
identification of a molecule mediating such a signal profoundly 
contributes to the understanding of the systems underlying 
B cell selections  during their maturation. 
Lymphocy~ are one of the most sensitive cells to immediate 
radiation-induced damage (7). In contrast to other cell types, 
quiescent lymphocytes are more sensitive than actively cy- 
cling cells, (7, 8), and the damaged cells are thought to un- 
dergo apoptosis. This process does not involve cell division 
and is referred to as interphase death. It is conceivable that 
some lymphocyte-specific signaling systems underlie inter- 
phase death in irradiation-induced damage, and that these 
lymphoid cell-specific signaling systems also work at a time 
when B cells undergo apoptosis during B cell selection. These 
assumptions prompted us to search for a mAb with radio- 
protective activity. 
In the present study, we established mAb KP/14, which 
was able to protect B cells from irradiation-dependent apop- 
toffs. RP/14 mAb was able to drive B cells in culture into 
cycling as well. The antigen recognized with R.P/14 (the RP 
antigen) was expressed on mature B cells but not on either 
immature or pre-B cells. Moreover,  B cells from X-linked 
immunoddident mice (XID) t (9) did not respond to RP/14 
1  Abbreviatiom used in this paper: BTK, Bruton's tyrosine kinase; XID, 
X-linked immunodefident. 
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antigen with B cells of wild type. The RP antigen was mono- 
meric and 105 kD in size. These results suggest that the RP 
antigen delivers  signals  into B cells for blocking apoptosis 
and proliferation. Moreover, the signal transduction through 
the RP antigen was shown to be defective in B cells with XID. 
Materials and Methods 
Mice and Rats.  BALB/c  and C57BL/6 mice were obtained from 
Japan SLC Co. (Hamamatsu, Japan), and used at 8-15 wk of age. 
CB17 scid/scid  mice were from Japan Clea Laboratories  Inc. (Tokyo, 
Japan). Wistar rats were purchased from Charles River Japan Inc. 
(Yokohama,  Japan). All mice and rats were maintained in the An- 
imal Facility  of  Saga Medical  School BALB/c.xid and C57BL/6.xid 
mice (10, 11) were kindly provided  by Dr. Alfred Singer (National 
Institutes  of Health,  Bethesda, MD)  through Dr.  Toshiyuki 
Hamaoka (Osaka University Medical School) and maintained in 
the Animal Facility  of the Institute of Medical Science (the Univer- 
sity of Tokyo). All experiments were performed according  to guide- 
lines in Saga  Medical  School and in the Institute of  Medical Science 
for the care and treatment of Animal Experimentation. 
mAbs.  Wistar  rats were immunized with spleen cells from 
BALB/c  mice. 3 d after the third immunization, spleen cells of im- 
munized rats were fused with SP2/0 myeloma  cells (obtained from 
the  American Type Culture Collection,  Rockville, MD).  The 
strategy for screening  of mAbs is described  in Results section. The 
established series (RP) of antibodies were all IgG2a/x. The anti- 
body against B220, RA3-6B2 (12) was provided by Dr. Shinya 
Murakami (Osaka University Dental School, Osaka, Japan). The 
rat  antibodies against mouse IgM (AM/3;  IgG2a/x)  and IgD 
(CS/15: IgG2a/K) were established in our laboratory. These anti- 
bodies were purified from ascitic fluids from CB17 scid/scid mice 
that had been transplanted with hybridomas. 
Protection  from Cell Death by Irradiation, or Dexaraethasone.  For 
expe6_ments of  irradiation-induced  apoptosis, spleen  cells  were placed 
in a 96-wetl plate (2 x  10S/well),  and precultured with antibodies 
(10 gg/ml) for 2 h. Then, cells were irradiated (100 or 200 tad) 
and cultured for an additional 18 h. As for dexamethasone-induced 
apoptosis, varying concentrations of dexamethasone (Wako Pure 
Chemical Industries, Ltd., Osaka, Japan) were added to cultures 
simultaneously with antibodies, and cells were cultured for 20 h. 
In these experiments, viable cells were determined after culture by 
a trypan blue dye exclusion test. Percentages of viable cells were 
determined by the formula: percent viable cells =  100  x  (viable 
cell number after culture/input cell number). The results were rep- 
resented as mean  +  SD for triplicate cultures. 
For measuring DNA contents, cells were harvested and fixed 
with 70% ethanol. Fixed cells were stained with PBS containing 
50/zg/ml propidium iodide (Sigma Chemical Co., St. Louis, MO) 
and 10/~g/ml RNase (Nippon Gene, Toyama,  Japan). After washing 
twice with PBS supplemented with 2% FCS and 0.1% sodium 
azide, cells were analyzed on a FACScan  |  (Becton Dickinson & 
Co., Mountain View, CA). 
Cell Pwliferation Assa~,.  Spleen  cells or T cell-depleted spleen 
cells were inoculated into a 96-well plate at 2  x  10S/well  (10) and 
cultured with or without mAb (10/~g/ml) for 2-3 d. The cultures 
were pulsed with 1 #Ci/well of [3H]TdR (ICN Radiochemicals, 
Irvine, CA) for the last 6 h of the culture. They were then har- 
vested onto glass fiber filters and the incorporated radioactivity  was 
determined in  a liquid  scintillation counter. The  results were 
presented as the average cpm  _+  SD from triplicate wells. 
Immunofluorescence Analysis.  Cells in  suspension (5  x  10  s 
calls/200 #1) were incubated for 20 rain on ice with mAbs, After 
two washes, FITC-labded mouse anti-rat ~ (MAR18.5) mAb was 
added for an additional 20-min incubation. Propidinm iodide was 
included during this incubation period and used as a gating param- 
eter to exclude dead ceUs. For dual staining, cells were incubated 
with a biotinylated antibody, and after washing twice, PE-labded 
avidin (Vector Laboratories Inc., Burlingame, CA) and a FITC- 
labeled antibody were added and incubated for 20 min on ice. In 
this case, propidium iodide was not included. Labeled cells were 
then analyzed using a FACScan  |  (Becton Dickinson & Co.). 
Cell Surface Biotinylation and Immunoprecipitation.  Cell surface 
biotinyhtion and immunoprecipitation  were carried out as described 
previously (13). Briefly, cells (5  x  107/ml) were washed twice 
with HBSS, and suspended in saline containing 100 mM Hepes 
(pH 8.0). Sulfosuccinimidobiotin  (Pierce Chemical Co., Rockford, 
IL) was added to call suspension at a concentration of 0.5 mg/ml. 
After a 40-min incubation at room temperature with occasional 
shaking, cells were washed and lysed in lysis buffer containing 50 
mM Tris/HC1 (pH 7.5), 150 mM NaC1, 1% Triton X-100, 50 mM 
iodoacetamide, I mM PMSF, 10 gg/ml soybean trypsin inhibitor, 
2 mM MgClz, 2 mM CaClz, and 0.1% sodium azide. After a 30- 
min incubation on ice and following centrifugation,  the cell ly- 
sates were recovered and incubated  with antibody-coupled  Sepharose 
4B for 2 h at 4~  After washing with lysis  buffer, bound proteins 
were subjected to SDS-PAGE, blotted onto a nitrocellulose mem- 
brane, and visualized with avidin-peroxidase  (Bio-Rad Laborato- 
ries, Richmond,  CA) followed by an appropriate substrate. 
Results 
Radiopwtective Activity ofmAbs.  We immunized rats with 
spleen cells from BALB/c mice, and fused with SP2/0 my- 
eloma cells. In an attempt to search for a molecule that modu- 
lates apoptosis,  mAbs were screened by an assay system for 
protective effects from apoptosis caused by low dose irradia- 
tion. Mouse spleen cells were cultured with supernatants from 
resultant hybridoma cells for 2-4 h at 37~  Spleen cells were 
then irradiated at 100-200 rad, cultured for another 18 h, 
and viable cells were counted. The supernatants with which 
more cells remained viable were selected and subjected to a 
subsequent cloning. Among over 2,000 of resultant hybridoma 
clones, 5 clones (RP/12, RP/14, RP/15, RP/16, and RP/19) 
were selected  and analyzed in this study because of their 
remarkable radioprotective activities. Since functional activi- 
ties of these five hybridoma clones were similar to each other 
and the antigen recognized with these antibodies appeared 
identical as judged by flow cytometry and immunoprecipita- 
tion experiments, the results obtained with RP/14 are shown 
in the present study, except the experiments of immunopre- 
cipitation in which the results obtained with RP/14 and RP/16 
are shown. Fig.  1,  one of representative results of a series 
of experiments repeated more than five times, showed the 
radioprotective activity of RP/14. Two to three times more 
spleen cells remained viable with RP/14 than those without 
antibody or with a control antibody. Then DNA contents 
of irradiated cells were examined with an aim to analyze apop- 
totic cells, because cells with subdiploid DNA corresponded 
to those undergoing apoptosis (14). For this experiment, ir- 
radiated spleen cells were harvested at earlier periods of time 
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tivity of ILP/14 on spleen cells. 
Spleen cells from C57BL/6 mice 
were cultured for 2 h  with  or 
without an antibody  before  irradi- 
ation.  Isotype-matched  rat 
anti-mouse  B220 mAb  (ILA3- 
6B2) was used as a control anti- 
body. Subsequently  cells  were  cul- 
tured for 18 h. Viable cells were 
counted by trypan blue dye exclu- 
sion, and percent viable calls are 
shown. The values are mean  _+ 
SD for triplicate cultures. 
(6 or 12 h) after the irradiation,  because in apoptotic cells, 
nuclear changes  including  DNA  degradation  precedes cell 
membrane death (15), and cells undergoing DNA degrada- 
tion still exclude trypan blue. As shown in Fig. 2, an inclu- 
sion of RP/14  reduced cells with  subdiploid DNA  in per- 
centage.  The  radioprotective  effect  of  RP/14  was  more 
remarkable at 6 h  after irradiation than that at 12 h after ir- 
radiation (Table 1). When cells were incubated on ice for 6  h 
after irradiation, as little as 0.6% of cells showed subdiploid 
DNA. Therefore DNA degradation is a metabolically active 
process, and RP/14 seemed to disturb this process. At higher 
dose irradiation of 2,000 rad, spleen cells were shown to die 
by necrosis rather than apoptosis (8). Under these conditions, 
RP/14  did not rescue spleen cells from irradiation-induced 
damage (data not shown). We also induced cell death by apop- 
tosis using dexamethasone (16)  and  examined the effect of 
RP/14  on its protection.  RP/14  was again effective in res- 
cuing spleen cells from dexamethasone-induced cell death (Hg. 
3). These results indicate that RP/14 can rescue spleen cells 
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Figure 2.  RP/14 reduced  percentage  of  calls with subdiploid  DNA that 
was undergoing apoptosis upon irradiation. DNA content of irradiated 
spleen  cells  were shown with propidium iodide. After irradiation  (200  tad), 
cells were cultured for 6 h, fixed  in 70% ethanol, stained with propidium 
iodide. Stained cells were analyzed on a PACScan  |  30,000 cells were 
analyzed. 
from apoptosis  induced  by irradiation  or dexamethasone. 
Tissue Distribution and Iramunoprecipitation of  the Target An- 
tigen Recognized  by RP/I4.  To characterize the antigen rec- 
ognized by RP/14 mAb (the RP antigen), we examined the 
tissue distribution of the RP antigen by immunofluorescence 
analysis.  Spleen,  lymph  nodes,  and bone marrow,  but  not 
thymus contained positive ceils for the RP antigen (data not 
shown). To analyze in more detail, dual staining was carried 
out  with  cells from  spleen or bone marrow  using  various 
mAbs (Fig. 4). The expression of the RP antigen in spleen 
cells was restricted on B220-positive cells (Fig. 4 A). Among 
Table  1.  RP/14  raAb Reduced Cells with Subdiploid DNA  that Underwent Apoptosis after Irradiation 
Spleen  cell  treatment 
Hour after  Cells with  Relative 
Experiment  RP/14  mAb  Irradiation  Irradiation  subdiploid DNA  increase 
10 I~g/ml  200 tad  %  % 
1  -  -  6  7.4  - 
-  +  28.3  20.9 
+  +  10.6  3.2 
2  -  -  12  17.4  - 
-  +  66.4  49.0 
+  +  41.3  23.9 
Spleen cells from BALB/c mice were cultured with RP/14 or control antibody (10 #g/ml) for 2 h before irradiation (200 rad).  Then, cells were 
cultured for additional 6 h (experiment 1) or 12 h (experiment 2), fixed  with 70% ethanol, and stained with propidium iodide. Percentage of cells 
with subdiploid DNA are shown. Relative increase (%) corresponds to the values from which percentages with cells cultured without irradiation 
was subtracted. The percentage of cells with subdiploid DNA was 0.6 when cells were incubated on ice for 6 h after irradiation (experiment 1). 
In both experiments, 3  x  104 cells were analyzed. 
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Figure  3.  Rescue  of  spleen 
cells from clexamethasoneqnduced 
apoptosis by RP/14 mAb. Spleen 
cells from BALB/c mice were cul- 
tured for 20 h  with or without 
dexamethasone at concentrations 
indicated in the figure. RP/14 or 
a  control  antibody  (anti-B220: 
RA3-6B2)  were present  during 
culture at a concentration of 10 
/zg/ml. Viable cells were counted 
by trypan blue dye exclusion, and 
percent viable cells are shown. The 
values are mean  _+  SD for tripli- 
cate cultures. 
them, cells expressing the tLP antigen appeared to bear bright 
B220, dull IgM, and bright IgD (Fig. 4, A, C, and E). This 
phenotype represents rather mature and long-lived B cells 
(17-19). 
In bone marrow, the RP antigen was expressed on B cells 
expressing bright B220 (Fig. 4 B), and dull IgM (Fig. 4 D), 
but not on pre-B cells, because the RP antigen was not ex- 
pressed on either B220  au" or IgM-negative cells. B cells in 
bone marrow with bright B220 and dull IgM are reported 
to be derived from long-lived recirculating B cells but not 
from newly generated B cells (17, 18). Therefore the expres- 
sion pattern of the RP antigen in bone marrow would be 
consistent with that in spleen. Collectively,  the RP antigen 
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Figure  4.  Dual staining of spleen and bone marrow cells with RP/14 
mAb and B cell markers. Spleen cells or bone marrow cells were stained 
with FITC-hbeled RP/14 mAb (horizontal axis) and biotinyhted antibodies 
against B220, IgM, or IgD (vertical axis).  Forward and side scatter were 
used as gating parameters  to ew.amine lymphoid cells in spleen and total 
nucleated cells in bone marrow.  The percentages of cells are indicated in 
each of the upper quadrants.  30,000 cells were analyzed. 
appears to be expressed on mature B cells but not either pre- 
B cells or newly generated B cells as judged by the two-color 
analysis with 8220, IgM and IgD. Immunoprecipitation  ex- 
periments were, then, performed to identify the antigen rec- 
ognized with RP/14 or RP/16. A monomeric protein was 
immunoprecipitated, and its molecular mass was approxi- 
mately 105 kD (Fig. 5). No differences in size were observed 
between reduced and nonreduced  (data not shown) condition. 
RP/14 Is Agonistic  to IgM + IgD + B  Cells.  Spleen ceils 
rescued from irradiation by RP/14 were harvested and cell 
surface markers were analyzed. Most of them expressed B220, 
IgM, and IgD as well as the RP antigen (data not shown). 
Therefore B  cells expressing the RP antigen would be al- 
lowed to survive by RP/14. Most cells rescued by RP/14 from 
irradiation or dexamethasone appeared to be blastic. This bhstic 
change occurred also to spleen cells cultured with RP/14 in 
the absence of irradiation or dexamethasone. Therefore R.P/14 
itself induces the blastic change on spleen cells. If RP/14 is 
agonistic, blastic cells should express the RP antigen. Spleen 
cells were cultured with or without RP/14 for 2 d, harvested, 
and then the RP antigen was stained (Fig. 6). Indeed, blasts 
generated by culturing with RP/14 expressed the RP antigen. 
These blasts  retained other B cell markers including B220, 
IgM, and IgD (data not shown). Thus, it would be B cells 
expressing  the RP antigen that showed blastic  change and 
were rescued from irradiation- or dexamethasone-dependent 
apoptosis. 
The  uptake  of  [3H]TdR  was  examined  to  determine 
whether or not blastic change of B cells achieved with RP/14 
proceed to B cell proliferation. As shown in Table 2, spleen 
cells showed remarkable uptake of [3H]TdR upon stimula- 
tion with RP/14. The response peaked around day 2-4, and 
Figure  5.  RP mAbs recognize 
a monomeric molecule with 105 
kD molecular mass. B lymphoma 
cell,  BCL1,  was  surface- 
biotinyhted, detergent-extracted, 
and precipitated  with RP/14- or 
RP/16-bound beads. Bound pro- 
teins were subjected to SDS-PAGE 
(9% acrylamide) under a reduced 
condition, blotted onto a nitrocel- 
lulose  membrane,  and  detected 
with avidin-peroxidase and appro- 
pilate substrates. 
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Figure 6.  Responding blasts to the stimulation with RP mAb express 
the RP antigen. Spleen ceUs  were cultured with (B) or without (A) RP/14 
mAb (10 #g/ml) for 2 d. Then, cells were stained with RP/14 followed 
by FITC-labeled mouse anti-rat  x mAb. In A, some R.P-positive blasts 
appeared in the upper right region. These cells seemed to have been al- 
ready activated in vivo. The percentages of cells are indicated in each of 
the upper quadrants. 
Table  2.  Proliferation of Spleen Cells Induced by RP/14 mAb 
[3H]TdK uptake 
mAb added  Experiment  Experiment 
10 #g/ml  cpm 
None  587  •  174  288  _+  34 
Control Ab  964  •  149  751  _+  141 
RP/14  61,660  •  3,374  27,626  _+  1,050 
Spleen cells from BALB/c mice were inoculated into a 96-wall microtiter 
plate (2  x  10  s ceils/wall), and cultured with or without antibodies for 
2 d. Cells were pulsed with 1 #Ci of [3H]TdR for the last 4 h of the 
culture,  and  cell-associated cpm  were  measured.  The  values were 







A  BALB/c 
0  ..... i'~, .....  i'g2  ..... ig, .... i~. 
B BALB/c.,,Yad 
Fluorescence  Intensity (Log) 
Figure 7.  Comparable  expression of the RP antigen on B 220-positive 
B cells with XID. Spleen cells from BALB/c  or BALB/c.xid  were stained 
with RP mAb and anti-B220 (RA3-6B2). B220-positive  cells were gated 
and the expression of the RP antigen was shown. 
then gradually declined (data not shown). We obtained similar 
proliferative responses by using T  cell-depleted spleen cells 
(Table 3). Moreover, spleen cells did increase in number when 
RP mAb was added to culture (data not shown). Thus, RP/14 
appeared to drive B cells into proliferation. After stimulation 
with RP/14, supematant from spleen cells were collected and 
the amount of IgM was determined by ELISA. No significant 
production of IgM was  observed  (data not  shown). 
B Cells with XID Do Not Respond to RP mA b in Spite of 
Comparable Expression of the RP Antigen to B Cells of Wild 
Typ~  The results that mature B cells expressed the RP an- 
tigen and were activated with RP/14 mAb prompted us to 
study B cells from XID mice (9) because the xid mutation 
results in drastic decrease in mature B cells bearing dull IgM, 
and bright IgD (20). At first, the expression of the RP an- 
tigen was studied. As shown in Fig. 7, the RP antigen was 
expressed  on B220-positive B  cells  from BALB/c.xid.  The 
amount of the RP antigen appeared  to be comparable be- 
tween BALB/c and BALB/c.xid.  Then, T cell-depleted spleen 
cells were cultured with RP/14 mAb. XID B cells did not 
Table  3.  Unresponsiveness  of X-linked Iraraunodeficient B Cells to RP mAb 
[~H]TdR uptake stimulated with:  (10 #g/ml) 
Mouse  None  Control Ab  RP/14  LPS 
c~m 
BALB/c  103  +  16  132  _+  35  37,702  •  2,020  33,067  +  3,167 
BALB/c.xid  58  •  15  108  •  28  100  •  11  3,364  •  375 
C57BL/6  89  •  12  137  •  22  46,678  +  1,503  24,172  •  2,008 
C57BL/6.xid  64  •  23  44  •  24  64  •  13  32,533  •  246 
T cell-depleted spleen cells from BALB/c or BALB/c.x/d mice were inocuhted into a 96-well microtiter plate and cultured with antibodies or LPS 
for 3 d. Anti-CD45 (RA3-6B2) mAb was used for an control antibody. Cells were pulsed with 1 #Ci of [3H]TdR for the last 6 h of the culture, 
and cell-associated cpm were measured. The values were mean +  SD for triplicate cultures. 
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3). As a control, B cells from BALB/c.xid and C57BL/6.xid 
showed good proliferative responses to LPS. Wild-type B cells 
from BALB/c or C57BL/6 responded to both RP/14 mAb 
and LPS. Similar  results were obtained with B cells from 
CI~/N mice (data not shown). RP/14 did not protect spleen 
cells from CBA/N mice against apoptosis induced by irradi- 
ation,  Neither uptake of [3H]TdR nor blastic  change was 
observed in CBA/N spleen cells when cultured with RP/14 
mAb. These results strongly suggest that signal transduc- 
tions through the RP antigen appear to be defective in XID 
mice. 
Discussion 
We established novel mAbs that are able to protect B cells 
from apoptosis induced by irradiation or dexamethasone. One 
of mAbs RP/14 can drive B cells into proliferation. The antigen 
recognized by RP/14 is approximately 105 kD in size and 
is expressed on mature B cells bearing IgM  a~, IgDb~s  ht, and 
B220b'~s  h~, but not on either pre-B cells or immature B cells. 
Because responding B cells are positive for the RP antigen, 
RP/14 would deliver a signal into mature B cells through 
the RP antigen. To our knowledge, no molecule  with similar 
molecular weight and expression profiles is reported, although 
NH2-terminal  amino acid sequencing and isolation of cDNA 
for the RP antigen is required to define that the RP antigen 
is novel. 
In contrast to other cell types, lymphocytes in a quiescent 
state are more vulnerable to irradiation-induced apoptosis than 
those in an actively dividing state (7, 8). Activation makes 
B cells resistant to irradiation (8). RP/14 protected B cells 
from irradiation-induced apoptosis. At the same time RP/14 
activated B cells as judged by a blastic change and drove them 
into proliferation. Moreover,  both rescued cells and blastic 
cells expressed the RP antigen. Therefore B cell activation 
and protection from apoptosis by RP/14 would be explained 
by a signal generated by RP/14. In other words, radioprotec- 
tive activity by RP/14 would stem from B cell activation by 
RP/14. A signal delivered with RP/14 through the RP antigen 
activates B cells, and activated B cells then would turn resis- 
tant against irradiation-induced apoptosis. Accordingly, pro- 
tection from apoptosis, a blastic change, and [3H[TdR up- 
take, all these readout systems would observe one phenomenon, 
B cell activation achieved by a signal with RP/14. 
Signals to B cells delivered by RP/14 mAb appear to be 
similar to that delivered by the antibody against CD40 (21). 
Although a mAb against murine CD40 has not been reported 
yet, the antibody against human CD40 is able to induce B 
cell proliferation and immunoglobulin secretion particularly 
in concert with antigen or anti-IgM, and cytokines such as 
IL-4 or IL-10 (22, 23). Moreover, anti-CD40 has been shown 
to protect germinal center cells from apoptosis (6), and a B 
cell line, WEHI231, from anti-IgM-mediated apoptosis (24). 
The signal through CD40 into B cells results in both activa- 
tion and protection from apoptosis, phenomena as were ob- 
served with the RP antigen. It is interesting to study the 
effect of RP/14 on anti-IgM-mediated apoptosis of WEHI231 
cells (24). 
The RP antigen can be, however, discriminated from CD40 
by the fact that the RP antigen is expressed  on B220b~ig  ht 
IgM  a~ IgDb~  ht B cells, but not on pre-B cells or immature 
B cells. On the contrary, an acquisition of human CD40 pre- 
cedes the expression of CD20, and shows a pan-B reactivity 
in peripheral lymphoid organs (22).  CD40 is expressed on 
germinal center cells (6), and plays critical roles in germinal 
center formation (5, 6, 25-29). However, it is unlikely that 
germinal center cells possess the bright expression of the RP 
antigen, because the RP antigen is expressed on IgD-positive 
B cells (Fig. 4), which do not reside in germinal center (6). 
The restricted expression of the RP antigen in B cell ontogeny 
might suggest a very specified role of the RP antigen in B 
cell activation or maturation as compared with CD40. 
It is well acknowledged that immature B cells in spleen 
can be discriminated from mature B cells on the basis of 
differential expression of B220, surface IgM, and surface IgD 
(17-19).  B  cells with  B220  d~l, IgMb'ig  ht,  and  IgD  aun  are 
supposed to belong to an immature B cell population that 
would be recently generated in the bone marrow. Long-lived 
mature B  cell  subpopulation has  B220b'ig  ht,  IgM  aun, and 
IgDb~  hr. Cell labeling studies with 5-bromo-2'-deoxyuridine 
(BrdU) revealed that the immature B cell population has rapid 
turn over rate whereas the mature B cell population is stable 
(18). Consequently it is assumed that some maturation stages 
exist between immature B cells and mature long-lived B cells 
(19). Although more information is required concerning the 
precise expression pattern of the RP antigen in association 
with other markers such as the heat stable antigen (19), it 
could be a transition stage from immature to mature B cells 
where the ILP antigen is acquired. In this regard, RP/14 would 
be useful as a novel marker for this transition stage. Moreover, 
because RP/14 is shown to deliver a signal into IgM-positive, 
IgD-positive B cells, the RP antigen itself might be, in some 
ways, implicated in this transition. Further studies are on- 
going to elucidate these issues. 
Mice with XID (9) lack a mature B cell population that 
normally develops late in ontogeny and expresses low IgM 
and high IgD (20). B cell maturation seemed to be arrested 
at a stage between immature and mature B cells. Taking the 
expression pattern of the RP antigen into consideration, we 
were interested in investigating the KP antigen on xid B cells. 
Although B220-positive B cells with x/d does express the RP 
antigen comparably to wild-type B cells (Fig. 6), B cells with 
xiddo not respond to the signal with RP/14. Recently a gene 
involved  in  X-linked agammaglobulinemia was identified 
(30, 31). The gene, btk which encodes a member of the src 
family of protein tyrosine kinases was mapped to the x/d region 
of the mouse X  chromosome. A  single conserved residue 
within the NH2-terminal unique region of Bruton's tyrosine 
kinase (Btk) was mutated in xid mice (32). Btk, for which 
the btk gene code is supposed to work in signal transmission 
which is indispensable for B cell maturation in human and 
mice. The results in the present study might suggest an in- 
dispensable role of Btk in transducing the signal with RP/14 
1222  B Cell Growth with a Novel Agonistic Antibody mAb.  However it is also  possible that a mutation in Btk 
indirectly affects a signaling complex used by activation with 
RP/14 mAb. 
While B cell production is intact (33, 34),  mice with xid 
have a difficulty  in maintaining a stable B cell pool in periph- 
eral lymphoid organs especially in competition with wild- 
type B cells (35). Maturation into a long-lived mature B cell 
would be prerequisite for joining a stable B cell pool. The 
acquisition of the RP antigen by B cells would occur at a 
transitory state from an immature to a mature state. Taken 
together with these issues, it would be possible that the signal 
through the RP antigen is involved in maturation itself or 
in maintaining a long-lived B cell pool. In this regard, the 
study of the RP antigen and the signal transduction through 
the RP antigen would be able to contribute to further un- 
derstanding of B cell maturation and activation in peripheral 
lymphoid organs. 
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